Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusagro reported for 9 months of 2024 by IFRS

11/11/24 AGRO

Element Group of Companies will supply components for SSJ 100 and MS-21

11/11/24 ELMT

Sberbank reports for 10 months of 2024 by RAS

11/11/24 SBER

Board of Directors of Rosneft Oil Company recommended dividends

11/8/24 ROSN

Bank Kuznetsky reported for 9 months of 2024 by RAS

11/8/24 KUZB

Rosseti Lenenergo reported for 9 months of 2024 by RA

11/8/24 LSNG

Ziyavudin Magomedov to pay Fesco more than $1 bln in debt

11/8/24 FESH

Arenadata Group's for 9 month revenue grew 2.1 times

11/8/24 DATA

Abrau-Durso expects to increase exports to 2 mln bottles

11/8/24 ABRD

PhosAgro reports for 9 months of 2024 by RAS

11/7/24 PHOR